Skip to content

Tommaso Cassano

2 papers in the library · 675 citations · publishing 2005-2023

Papers

Sort Most recent Most cited

Hexahydrocannabinol Pharmacology, Toxicology, and Analysis: The First Evidence for a Recent New Psychoactive Substance.

Current Neuropharmacology 2023 Silvia Graziano, Maria Rosaria Varì, Simona Pichini et al.

During the last two years, hexahydrocannabinol (HHC), the hydrogenated derivative of tetrahydrocannabinol has been freely sold by internet websites as a "legal" replacement to THC and cannabis in a range of highly attractive branded and unbranded products, some of which are sold as "legal highs". Potentially, there could be a large demand for HHC products by individuals in Europe and...

DOI: 10.2174/1570159x21666230623104624 (opens in new tab) Full text (opens in new tab) Hexahydrocannabinol New psychoactive substances Phytocannabinoids Synthetic cannabinoids

Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

Proceedings of the National Academy of Sciences December 13, 2005 Gabriella Gobbi, Francis Rodriguez Bambico, Regina A. Mangieri et al. 675 citations

Although anecdotal reports suggest that cannabis may be used to alleviate symptoms of depression, the psychotropic effects and abuse liability of this drug prevent its therapeutic application. The active constituent of cannabis, delta9-tetrahydrocannabinol, acts by binding to brain CB1 cannabinoid receptors, but an alternative approach might be to develop agents that amplify the actions of...

DOI: 10.1073/pnas.0509591102 (opens in new tab) Anandamide Endocannabinoid system Pharmacology Cannabinoid receptor +5